FDA Authorizes Simparica TRIO for Screwworm in Dogs
Silver Spring, Maryland, August 13, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Silver Spring, Maryland, August 13, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...
SILVER SPRING, Maryland, June 11, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...
